RPhLink.com  The #1 Link for Pharmacists and Pharmacy Techs  Call 1-877-RPhLink

Bayer Recall      August 10, 2001 This letter is to provide clarification on the letter sent August 8 regarding the voluntary withdrawal of Baycol® (cerivastatin sodium) from the market.  Bayer is conducting a voluntary withdrawal down to the pharmacy level, and the Food and Drug Administration (FDA) agreed with our decision.  According to the FDA Talk Paper, "Patients who are taking Baycol should consult with their physicians about switching to alternate medications to control their cholesterol levels.  Patients taking Baycol who are experiencing muscle pain or are taking gemfibrozil should discontinue Baycol immediately and consult their physician."  A copy of the FDA Talk Paper on the market withdrawal is available at the FDA web site, www.fda.gov. Bayer will reimburse patients for unused medications.  If patients ask for information regarding reimbursement for unused medication, please have them call 1-877-921-1313.  Thank you.